Absence and rescue of morphine withdrawal in GIRK/Kir3 knock-out mice.

The Journal of Neuroscience : the Official Journal of the Society for Neuroscience
Hans G CruzC Lüscher

Abstract

Although morphine induces both analgesia and dependence through mu-opioid receptors (MORs), the respective contributions of the intracellular effectors engaged by MORs remain unknown. To examine the contribution of G-protein-gated inwardly rectifying K(+) (GIRK, Kir3) channels to morphine dependence and analgesia, we quantified naloxone-precipitated withdrawal behavior and morphine analgesia using GIRK knock-out ((-/-)) mice. The morphine withdrawal syndrome was strongly attenuated, whereas morphine analgesia was mostly preserved in mice lacking both GIRK2 and GIRK3 (GIRK2/3(-/-) mice). In acute slices containing the locus ceruleus (LC) from GIRK2/3(-/-) mice, the increase in spontaneous firing typically associated with morphine withdrawal was absent. Moreover, although morphine elicited normal presynaptic inhibition in the LC, postsynaptic GIRK currents were completely abolished in GIRK2/3(-/-) mice. Altogether, these data suggested that morphine-evoked postsynaptic inhibition of the LC was required for the induction of dependence. Consistent with this hypothesis, morphine withdrawal behavior was rescued in GIRK2/3(-/-) mice by ablation of adrenergic fibers using the neurotoxin N-(2-chloroethyl)-N-ethyl-2-bromobenzylamine. Our...Continue Reading

References

Nov 1, 1995·Naunyn-Schmiedeberg's Archives of Pharmacology·R MaldonadoB P Roques
Feb 4, 1997·Proceedings of the National Academy of Sciences of the United States of America·S SignoriniM Stoffel
Apr 1, 1997·Trends in Pharmacological Sciences·M J ChristieC E Bellchambers
May 23, 1998·Annual Review of Pharmacology and Toxicology·R J Miller
Feb 24, 2001·Clinical and Experimental Pharmacology & Physiology·S L Borgland
Feb 2, 2002·Psychopharmacology·Y A BlednovR A Harris
Mar 14, 2002·Gene·Kevin WickmanDavid E Clapham
Dec 21, 2002·Proceedings of the National Academy of Sciences of the United States of America·Y A BlednovR A Harris
Dec 24, 2002·Proceedings of the National Academy of Sciences of the United States of America·Igor MitrovicAllan I Basbaum
Aug 9, 2003·Pflügers Archiv : European journal of physiology·Eric GrouzmannLucia Mazzolai
Jan 28, 2004·Nature Neuroscience·Hans G CruzChristian Lüscher
Mar 19, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Cheryl L MarkerKevin Wickman
Apr 6, 2004·Trends in Pharmacological Sciences·Eric J Nestler
Feb 19, 2005·Proceedings of the National Academy of Sciences of the United States of America·Amyaouch BradaïaChristian Lüscher
Apr 15, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Xixi Chen, Daniel Johnston
Jun 25, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Colleen A McClungVenetia Zachariou
Dec 13, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Lev KoyrakhKevin Wickman
Apr 28, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Ming-Hu HanEric J Nestler
Nov 24, 2006·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Cheryl L MarkerKevin Wickman
Jan 16, 2008·Genes, Brain, and Behavior·M Pravetoni, K Wickman

❮ Previous
Next ❯

Citations

Dec 19, 2013·Nature Communications·Maïly DevilliersAlain Eschalier
Apr 16, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Toru KobayashiKazutaka Ikeda
Apr 15, 2010·Nature Reviews. Neuroscience·Christian Lüscher, Paul A Slesinger
Jul 5, 2012·Cold Spring Harbor Perspectives in Medicine·Michelle S Mazei-Robison, Eric J Nestler
Mar 6, 2010·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Anuradha MadhavanJennifer L Whistler
Feb 14, 2016·Psychopharmacology·Irina N KrasnovaJean Lud Cadet
Oct 2, 2009·Peptides·Richard J Bodnar
Jun 19, 2010·Journal of Neurochemistry·Devinder AroraKevin Wickman
Sep 18, 2010·The European Journal of Neuroscience·Francisco CiruelaRafael Luján
Mar 26, 2016·Alcoholism, Clinical and Experimental Research·Megan E TippsKari J Buck
May 10, 2015·The International Journal of Neuropsychopharmacology·Nerea LlamosasMaria Torrecilla
Nov 26, 2013·Trends in Neurosciences·Rafael LujánKevin Wickman
Jan 28, 2014·Trends in Neurosciences·Christoforos Tsantoulas, Stephen B McMahon
Mar 27, 2012·Neuron·Kelly R TanChristian Lüscher
Oct 9, 2012·The International Journal of Neuropsychopharmacology·María TorrecillaLuisa Ugedo
Feb 1, 2017·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Sudarat NimitvilaiJohn J Woodward
Apr 15, 2015·Current Opinion in Supportive and Palliative Care·Christoforos Tsantoulas
May 28, 2011·Reviews in the Neurosciences·Adam StewartAllan V Kalueff
Dec 16, 2016·Evidence-based Complementary and Alternative Medicine : ECAM·Noor Azuin SulimanZulkhairi Amom
Mar 14, 2020·Pharmacology & Therapeutics·Jérôme BusserollesAlain Eschalier
Feb 12, 2017·Trends in Pharmacological Sciences·Robert A RifkinPaul A Slesinger
Jun 13, 2021·Science Advances·Lajos V KeményDavid E Fisher

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.